{"disease":{"id":"staphylococcus-aureus-bacteremia","name":"staphylococcus aureus bacteremia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03908086","title":"Bloodstream Infections in Patients With Rheumatoid Arthritis","phase":"","overall_status":"COMPLETED","enrollment_count":6000000,"lead_sponsor_name":"Sabine Dieperink","has_results":false},{"nct_id":"NCT05137119","title":"Staphylococcus Aureus Network Adaptive Platform Trial","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"University of Melbourne","has_results":false},{"nct_id":"NCT06574399","title":"Identification and Validation of Clinical Phenotypes in Staphylococcus Aureus Bacteremia and Their Association With Mortality and Development of Complicated Bacteremia","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","has_results":false},{"nct_id":"NCT05862025","title":"Evaluation of the Usefulness of Echocardiography in Patients With Staphylococcus Aureus Bacteremia (ET-AUREUS Study).","phase":"NA","overall_status":"UNKNOWN","enrollment_count":470,"lead_sponsor_name":"Puerta de Hierro University Hospital","has_results":false},{"nct_id":"NCT03138733","title":"Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":390,"lead_sponsor_name":"Basilea Pharmaceutica","has_results":true},{"nct_id":"NCT06695832","title":"Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":369,"lead_sponsor_name":"Hospital Universitari de Bellvitge","has_results":false},{"nct_id":"NCT03514446","title":"Seven Versus Fourteen Days of Treatment in Uncomplicated Staphylococcus Aureus Bacteremia","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":284,"lead_sponsor_name":"Thomas Benfield","has_results":false},{"nct_id":"NCT04160468","title":"Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":259,"lead_sponsor_name":"ContraFect","has_results":true},{"nct_id":"NCT02476487","title":"The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia","phase":"NA","overall_status":"COMPLETED","enrollment_count":143,"lead_sponsor_name":"Rambam Health Care Campus","has_results":false},{"nct_id":"NCT06249451","title":"Staphylococcus Aureus Bacteraemia (SAB)-Support-Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"University Medicine Greifswald","has_results":false},{"nct_id":"NCT03163446","title":"Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":121,"lead_sponsor_name":"ContraFect","has_results":true},{"nct_id":"NCT05184764","title":"Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Armata Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03089697","title":"Phase IIa Clinical Study of N-Rephasin® SAL200","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"Intron Biotechnology, Inc.","has_results":true},{"nct_id":"NCT03761953","title":"Oritavancin for Staphylococcus Aureus Infections in Opioid Users","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Pennsylvania","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}